HPC Injection is indicated-
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
It is not known whether it is safe to consume alcohol with HPC Injection. Please consult your doctor.
HPC Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
HPC Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Nonhormonal contraceptives are preferred in breastfeeding women, especially during the first 4 weeks of postpartum
HPC Injection does not usually affect your ability to drive.
There is limited information available on the use of HPC Injection in patients with kidney disease. Please consult your doctor. This medicine contains progesterone which can cause fluid retention in patients with underlying kidney disease.
HPC Injection is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
HPC Injection is a progestin (female hormone). It works by modulating the immune response of the mother to prevent the rejection of the embryo and allow its attachment to the uterus. This prevents miscarriage and helps lower the risk of premature birth in women who have had one premature delivery in the past.
Inform your doctor immediately if you have pain in the chest, groin, or legs, difficulty with breathing, sudden severe headache, slurred speech, sudden unexplained shortness of breath, a sudden loss of coordination, or vision changes while using this medicine.
Pregnant women who use HPC Injections are less likely to deliver their babies too soon by reducing the risk of premature labor (preterm birth). In women who have already experienced one premature birth, it lowers the risk of premature birth and prevents miscarriage. Only doctors or those working under their supervision may administer HPC Injections. You should consider it to be medical advice. Your doctor will determine how much medication you require and for how long. As long as it has been prescribed for you, you should administer this injection.
The mechanism by which progesterone prevents preterm delivery is unknown, despite the fact that many potential pathways are involved. Progesterone regulates the female reproductive system and is crucial for successful embryo implantation and pregnancy maintenance. It binds to progesterone receptors in numerous organs, including the uterus, ovaries, breasts, and central nervous system, to accomplish this. Neither PR-A nor PR-B has a single isoform. Progesterone, which these receptors bind, controls the transcription of genes.
Progestin is HPC Injection (female hormone). It functions by regulating the mother's immune response to stop the embryo from being rejected and to enable its attachment to the uterus. In women who have already experienced one premature birth, this helps reduce the risk of miscarriage and lowers the likelihood of premature birth.
Administer 500 mg or 250 mg intramuscularly once a week. Start the course of treatment between 16 weeks and 20 weeks and 6 days after conception. Maintain weekly administration until week 37 (36 weeks, 6 days through delivery), whichever comes first.
Drug interactions might alter how your drugs function or raise the possibility of major negative side effects. All probable medication interactions are not included in this text. Keep a list of everything you use, including herbal items, prescriptions, and over-the-counter medications, and provide it to your doctor and pharmacist. Without your doctor's consent, never start, stop, or change the dosage of any medications.
Pregnancy is classified as Category B. There are no sufficient and well-controlled trials in pregnant women during the first trimester. In a trial of pregnant women receiving the medicine during their second and third trimesters, as well as a follow-up safety analysis of their infants, teratogenic risks to infants following in-utero exposure to the drug were not demonstrated. It is not meant to interrupt active premature labor; the drug's impact in this situation is uncertain.
Lactation: Progestins were found in detectable concentrations in the breast milk of women using progestins. Progestins have no negative effects on breastfeeding performance, infant health, growth, or development. At 37 weeks of pregnancy or when the baby is born, stop taking the medicine.
Store between 15°C and 30°C at a controlled room temperature. Protects against the light. Keep out of children's reach.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.